About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×
news
Company News Events Insights Webinars Virtual Tours
Diastereomeric Salt Resolution for Separating Chiral Compounds on Larger Scale at BioDuro
Beijing, March 23, 2018 – The requirement to produce chiral compounds as single enantiomers/diastereoisomers for pharmaceutical applications is well understood. The predominant method for generating chiral molecules, in the in
March 23, 2018
Using the Dr. Jekyll of Chemical Compounds to Advance Drug Synthesis
Beijing, March 22, 2018 – Sulfuryl fluoride gas is the chemical equivalent of Mr. Hyde. Like the fictional monster, it’s dangerous and difficult to work with. But by inventing a process that creates a new substance called [4-(
March 22, 2018
Production of Recombinant Proteins at BioDuro
Beijing, March 20, 2018 – BioDuro has built-up the capability for the production of high quality recombinant proteins to meet our customer’s needs for biochemical, biophysical and structural biology (X-ray, NMR) studies. We pr
March 20, 2018
BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent
Beijing, March 19, 2018 – PRNewswire – BioDuro, LLC, a global life science research and development organization, announces the creation of AISF ([4-(Acetylamino)phenyl]-ImidodiSulfuryl diFluori
March 19, 2018
BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities
San Diego, March 5, 2018 – PR Newswire – BioDuro LLC, a leading global life sciences contract research and development organization, announced today the acquisition of Molecular Response LLC and its w
March 05, 2018
Total 84 12...91011121314151617
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all